Crb 65 Score Calculator
Assess community-acquired pneumonia severity using CRB-65 criteria without lab tests. Enter values for instant results with step-by-step formulas.
Reviewed for accuracy by Rahul Singh, Health & Wellness Specialist
Medical disclaimer: This calculator is provided for educational and informational purposes only and does not constitute medical advice, diagnosis, or treatment. Results are general estimates and may not reflect your individual circumstances. Always consult a qualified healthcare professional before making decisions about your health.
Formula
CRB-65 Score = C + R + B + 65 (each criterion = 1 point, range 0-4)
C = Confusion (new mental confusion, AMTS <= 8). R = Respiratory rate >= 30 breaths/min. B = Blood pressure (systolic < 90 mmHg or diastolic <= 60 mmHg). 65 = Age >= 65 years. Each positive criterion scores 1 point for a maximum of 4.
Worked Examples
Example 1: Low-Risk Outpatient Assessment
Problem:A 45-year-old patient presents with cough, fever, and chest X-ray showing right lower lobe consolidation. The patient is alert and oriented, respiratory rate is 22/min, blood pressure is 130/80 mmHg.
Solution:CRB-65 Criteria Assessment: C - Confusion: No (0 points) R - Respiratory Rate >= 30: No, RR = 22 (0 points) B - Low Blood Pressure: No, BP = 130/80 (0 points) 65 - Age >= 65: No, age = 45 (0 points) Total CRB-65 Score = 0
Result:Score 0 (Low Risk) | 30-day mortality ~0.9% | Outpatient treatment appropriate
Example 2: High-Risk Hospital Admission
Problem:A 72-year-old patient presents with productive cough for 3 days. The patient is confused and disoriented to time, respiratory rate is 34/min, blood pressure is 85/55 mmHg.
Solution:CRB-65 Criteria Assessment: C - Confusion: Yes, disoriented (1 point) R - Respiratory Rate >= 30: Yes, RR = 34 (1 point) B - Low Blood Pressure: Yes, SBP 85 < 90 (1 point) 65 - Age >= 65: Yes, age = 72 (1 point) Total CRB-65 Score = 4
Result:Score 4 (High Risk) | 30-day mortality ~31.2% | Urgent admission, consider ICU
Frequently Asked Questions
What is the CRB-65 score and how is it different from CURB-65?
The CRB-65 score is a simplified clinical prediction tool used to assess the severity of community-acquired pneumonia (CAP) in adults. It evaluates four criteria: Confusion, Respiratory rate of 30 or more per minute, low Blood pressure (systolic less than 90 or diastolic 60 or below), and age 65 or older. Unlike the CURB-65 score, the CRB-65 does not require measurement of blood urea nitrogen (BUN), making it ideal for use in primary care, outpatient settings, and emergency departments where laboratory results are not immediately available. The CRB-65 was developed by Bauer and colleagues and has been validated in multiple large studies across different healthcare systems.
How is the CRB-65 score interpreted for clinical decision making?
The CRB-65 score ranges from 0 to 4 points, with each criterion contributing one point. A score of 0 indicates low risk with an estimated 30-day mortality of approximately 0.9 percent, and these patients can typically be managed as outpatients with oral antibiotics. A score of 1 to 2 suggests moderate risk with mortality ranging from 5.2 to 12 percent, and hospitalization should be considered based on overall clinical assessment. A score of 3 to 4 represents high risk with mortality exceeding 31 percent, requiring urgent hospital admission and possible intensive care unit evaluation. The score provides a quick initial assessment but should always be supplemented with clinical judgment.
When should the CRB-65 score be used instead of CURB-65?
The CRB-65 is specifically designed for situations where laboratory testing is not readily accessible, making it the preferred tool in general practice, urgent care clinics, nursing homes, and initial emergency triage before blood work returns. It is endorsed by the British Thoracic Society and the National Institute for Health and Care Excellence (NICE) as a validated bedside assessment tool. The CRB-65 performs comparably to the CURB-65 in predicting 30-day mortality, with studies showing similar area under the receiver operating characteristic curve values. However, when BUN results are available, the CURB-65 may provide slightly better discrimination between risk groups, particularly for identifying patients who need ICU admission.
What defines confusion in the CRB-65 scoring criteria?
Confusion in the CRB-65 score refers to new-onset mental confusion, which is typically assessed using the Abbreviated Mental Test Score (AMTS). A patient scores positive for confusion if the AMTS is 8 or less out of 10, indicating significant cognitive impairment. The AMTS tests orientation (time, place, recognition of persons), memory (recall an address, dates of World War II, current monarch or president), and concentration (counting backward from 20). In practice, clinicians often use a simpler assessment of whether the patient is oriented to person, place, and time, or has any new disorientation. It is important to establish that the confusion is new and not a baseline cognitive state, particularly in elderly patients with pre-existing dementia.
What are the limitations of the CRB-65 score?
The CRB-65 has several important limitations that clinicians should consider. First, it does not account for comorbidities such as COPD, diabetes, heart failure, or immunosuppression, which significantly affect pneumonia outcomes. Second, it may underestimate severity in younger patients with severe sepsis who do not meet the age criterion. Third, the score was primarily validated in European populations and may not perform identically in all demographics. Fourth, vital sign criteria use fixed thresholds that do not account for individual baseline values, such as patients with chronically low blood pressure. Finally, the score does not incorporate oxygen saturation, radiographic findings, or inflammatory markers that may indicate severe disease requiring escalated care.
How does age affect pneumonia severity and the CRB-65 score?
Age is a significant independent predictor of pneumonia mortality, which is why age 65 or older contributes one point to the CRB-65 score. Older adults have higher pneumonia mortality due to declining immune function (immunosenescence), reduced respiratory reserve, increased prevalence of comorbidities, and impaired ability to mount a febrile response that could delay diagnosis. Studies show that 30-day mortality for community-acquired pneumonia is approximately 1 to 2 percent in patients under 65 but rises to 10 to 15 percent in those over 65 and exceeds 25 percent in those over 85. However, the binary age threshold of 65 is a simplification because risk increases continuously with age, and some younger patients with multiple comorbidities may have worse outcomes than healthy older individuals.
Can the CRB-65 be used in hospital-acquired pneumonia?
The CRB-65 was specifically developed and validated for community-acquired pneumonia (CAP) and is not designed for hospital-acquired pneumonia (HAP) or ventilator-associated pneumonia (VAP). Hospital-acquired pneumonia involves different pathogens (often multidrug-resistant organisms like MRSA and Pseudomonas), different patient populations (already ill, post-surgical, or immunocompromised), and different prognostic factors than CAP. For HAP and VAP, clinicians should use severity scores specifically designed for these conditions, such as the Clinical Pulmonary Infection Score (CPIS) or general ICU severity scores like APACHE II or SOFA. Applying the CRB-65 to hospital-acquired infections would likely underestimate the true risk and lead to inadequate management decisions.
What antibiotics are typically recommended based on CRB-65 risk stratification?
Antibiotic selection based on CRB-65 stratification follows established pneumonia treatment guidelines. For low-risk patients (CRB-65 score of 0) managed as outpatients, first-line treatment is typically amoxicillin 500 mg three times daily, with a macrolide (azithromycin or clarithromycin) or doxycycline as alternatives for penicillin-allergic patients. For moderate-risk patients (score 1-2) requiring hospitalization, combination therapy with amoxicillin-clavulanate plus a macrolide, or a respiratory fluoroquinolone (levofloxacin or moxifloxacin) as monotherapy, is commonly used. High-risk patients (score 3-4) typically receive intravenous broad-spectrum antibiotics such as piperacillin-tazobactam or a third-generation cephalosporin combined with a macrolide. Local antibiograms and resistance patterns should guide specific choices.
How should oxygen saturation be factored alongside the CRB-65 score?
While oxygen saturation (SpO2) is not included in the CRB-65 criteria, it provides critical additional information for pneumonia severity assessment. The British Thoracic Society recommends that any patient with SpO2 below 92 percent on room air should be considered for hospital admission regardless of CRB-65 score, as hypoxemia independently predicts adverse outcomes and may require supplemental oxygen therapy. Some experts advocate using an expanded CRB-65-Ox score that adds one point for SpO2 below 90 percent, improving the predictive accuracy of the tool. In practice, a patient with CRB-65 of 0 but SpO2 of 88 percent should not be sent home for outpatient management. The combination of CRB-65 plus pulse oximetry provides a more comprehensive bedside assessment than either measurement alone.
What is the evidence base supporting the CRB-65 score for pneumonia assessment?
The CRB-65 score has been validated in numerous large-scale studies across multiple countries and healthcare settings. The original validation by Bauer and colleagues in 2006 included over 1,000 patients and demonstrated strong predictive accuracy for 30-day mortality with an area under the ROC curve of approximately 0.79. A subsequent meta-analysis by McNally and colleagues analyzing over 40,000 patients confirmed the discriminatory ability of CRB-65 across different populations. The German CAPNETZ study, one of the largest prospective pneumonia cohort studies, provided further validation in over 6,000 patients. The tool is formally recommended in guidelines from the British Thoracic Society, NICE, and the European Respiratory Society. Its simplicity and requirement for no laboratory tests make it particularly valuable for initial triage decisions.
References
Background & Theory
History
Reviewed for accuracy by Rahul Singh, Health & Wellness Specialist · Editorial policy
Related Calculators
🧮Curb-65 Score Calculator
Assess pneumonia severity and determine inpatient vs outpatient treatment using CURB-65.
🧮Chads2 Score Calculator
Calculate the CHADS2 stroke risk score for patients with non-valvular atrial fibrillation.
🧮Cha2ds2-Vasc Score Calculator
Calculate CHA2DS2-VASc score for stroke risk stratification in atrial fibrillation patients.
🧮Has-Bled Score Calculator
Assess bleeding risk in patients on anticoagulation using the HAS-BLED scoring system.
🧮HEART Score Calculator for Chest Pain Risk
Risk-stratify emergency department patients with chest pain using the HEART score.
🧮TIMI Risk Score Calculator
Calculate the TIMI risk score for STEMI and UA/NSTEMI patients.